Hmciso 10mg Soft Gelatin Capsule contains isotretinoin, a retinoid derivative primarily indicated for the treatment of severe recalcitrant nodular acne that has not responded adequately to conventional therapies such as systemic antibiotics and topical agents. Isotretinoin exerts its therapeutic effect by reducing sebaceous gland size and sebum production, normalizing follicular keratinization, and exhibiting anti-inflammatory properties, thereby addressing the multifactorial pathogenesis of acne. Each soft gelatin capsule delivers 10mg of isotretinoin, facilitating precise dosing tailored to patient weight and clinical response. Due to its potent teratogenicity, isotretinoin therapy mandates stringent pregnancy prevention measures, including negative pregnancy tests prior to initiation and regular monitoring throughout treatment. Common adverse effects include mucocutaneous dryness, cheilitis, elevated liver enzymes, and hyperlipidemia; thus, periodic laboratory evaluations are recommended. Patients should be advised to avoid vitamin A supplementation and to report any signs of depression or visual disturbances promptly. Hmciso 10mg is contraindicated in pregnancy, hypersensitivity to isotretinoin, and patients with pre-existing hepatic or lipid abnormalities. This medication should be prescribed and monitored by healthcare professionals experienced in acne management to optimize therapeutic outcomes while minimizing risks.